Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Hecht

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Virchows Archiv. A, Pathological Anatomy and Histology|January 1, 1980
[Evolution in the early changes in the establishment of arterial thrombi (author's transl)]W Hofmann, T Rommel, T Schaupp, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Provider assessment of adherence to HIV antiretroviral therapyD R Bangsberg, F M Hecht, H Clague, et al.
Journal of Clinical Microbiology|March 4, 2000
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5T Elbeik, E Charlebois, P Nassos, et al.
JAMA|November 4, 1998
Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study GroupA B Bindman, D Osmond, F M Hecht, et al.
Annals of Internal Medicine|November 30, 1999
Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study GroupD H Osmond, A B Bindman, K Vranizan, et al.
AIDS (London, England)|July 9, 1999
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyS G Deeks, F M Hecht, M Swanson, et al.
Oral Diseases|October 2, 2008
Prevalence of oral disease among adults with primary HIV infectionF J Owotade, C H Shiboski, L Poole, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infectionS A Stranford, J C Ong, B Martinez-Marino, et al.
Blood|January 3, 2001
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapyA M Schito, E Vittinghoff, F M Hecht, et al.
The American Journal of Medicine|April 1, 1995
Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial GroupJ Wheat, R Hafner, A H Korzun, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Virchows Archiv. A, Pathological Anatomy and Histology|January 1, 1980
[Evolution in the early changes in the establishment of arterial thrombi (author's transl)]W Hofmann, T Rommel, T Schaupp, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Provider assessment of adherence to HIV antiretroviral therapyD R Bangsberg, F M Hecht, H Clague, et al.
Journal of Clinical Microbiology|March 4, 2000
Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5T Elbeik, E Charlebois, P Nassos, et al.
JAMA|November 4, 1998
Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study GroupA B Bindman, D Osmond, F M Hecht, et al.
Annals of Internal Medicine|November 30, 1999
Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study GroupD H Osmond, A B Bindman, K Vranizan, et al.
AIDS (London, England)|July 9, 1999
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyS G Deeks, F M Hecht, M Swanson, et al.
Oral Diseases|October 2, 2008
Prevalence of oral disease among adults with primary HIV infectionF J Owotade, C H Shiboski, L Poole, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infectionS A Stranford, J C Ong, B Martinez-Marino, et al.
Blood|January 3, 2001
Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapyA M Schito, E Vittinghoff, F M Hecht, et al.
The American Journal of Medicine|April 1, 1995
Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial GroupJ Wheat, R Hafner, A H Korzun, et al.
Pageof 5